ArticleCancer cell international2021

Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China.

Yun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.